U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT06858345) titled 'Study of Maternal and Fetal Cardiovascular Function in Hypertensive States of Pregnancy' on Feb. 27.
Brief Summary: The pharmacological treatment strategy is then tailored to the underlying hemodynamic phenotype of each patient. That is, rather than applying a one-size-fits-all treatment for all patients, therapy is tailored to the specific characteristics of how the cardiovascular system functions in each patient (e.g., whether the problem is more related to blood volume, vascular resistance, cardiac output, etc.). The goal is to personalize therapy to more effectively treat hypertensive states of pregnancy.
Study Start Date: Jan....